Hedayati-Moghaddam MR, Soltanian H, Ahmadi-Ghezeldasht S. Occult hepatitis C virus infection in the Middle East and Eastern Mediterranean countries: A systematic review and meta-analysis. World J Hepatol 2021; 13(2): 242-260 [PMID: 33708353 DOI: 10.4254/wjh.v13.i2.242][Reference Citation Analysis]
2
Abd Alla MDA, Dawood RM, Rashed HAE, Farrag G, Ammar IAE, Mahmoud MMA, Salum GM, Altanbouly AMA, El Meguid MA, Awady MKE. Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes. Arch Virol 2021;166:1071-81. [PMID: 33533976 DOI: 10.1007/s00705-021-04969-4][Reference Citation Analysis]
3
Abd Alla MDA, Elibiary SA, Elshaboury RH, Wu GY, Dawood RM, El Awady MK. HCV Therapy Follow-up Fractionation (CTF2) by Intra-PBMC Nested RNA PCR Recognizes Early Virologic Response and Relapse. J Clin Transl Hepatol 2018;6:147-54. [PMID: 29951359 DOI: 10.14218/JCTH.2017.00077][Cited by in Crossref: 1][Article Influence: 0.3][Reference Citation Analysis]